NAD+ Benefits: Clinical Evidence & Personalization

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy metabolism, DNA repair, and mitochondrial function. Recent research has explored NAD+ supplementation for aging-related decline, though evidence remains emerging and individualized assessment is critical.

Choosing whether to pursue NAD+ therapy requires understanding your current metabolic and cellular status. At PlexusDx, we emphasize precision-guided decisions: biomarker evaluation and genetic insights help providers identify whether NAD+ support aligns with your specific health profile and goals.

How NAD+ Functions in Cellular Health

NAD+ acts as a crucial electron carrier in mitochondrial respiration, enabling ATP (energy) production. It also activates sirtuins and PARP enzymes, which regulate DNA repair, stress resistance, and cellular aging pathways—processes that naturally decline with age.

NAD+ levels decrease approximately 50% between age 20 and 60, correlating with increased fatigue, cognitive decline, and metabolic dysfunction. Supplementation aims to restore these reserves, though clinical efficacy depends on baseline NAD+ status and individual metabolic context.

NAD+ Precursors and Their Clinical Evidence

Multiple NAD+ precursors exist, including NMN, NR, niacin, and tryptophan. Each has distinct bioavailability, tissue penetration, and evidence profiles. The choice of precursor should reflect your baseline status and provider assessment, not generic market claims.

NAD+ Precursor	Key Mechanism	Clinical Evidence Level	Typical Dosing Range
NMN (Nicotinamide Mononucleotide)	Direct NAD+ pathway; rapid cellular uptake	Mouse/early human studies; limited long-term RCTs	250–1000 mg daily
NR (Nicotinamide Riboside)	Alternative NAD+ synthesis route; GI-stable	Phase II human trials; mixed muscle and metabolic outcomes	250–1000 mg daily
Niacin (Vitamin B3)	Rate-limiting precursor; well-established metabolism	Decades of evidence; highest efficacy in dyslipidemia	500–2000 mg daily
Tryptophan (de novo pathway)	Endogenous NAD+ synthesis; slower accumulation	Foundational biochemistry; limited targeted supplementation studies	2–5 grams daily

Biomarker Assessment Before NAD+ Supplementation

Baseline NAD+ levels, mitochondrial function markers, and energy metabolism assessment inform whether supplementation is appropriate. Fasting glucose, lactate, carnitine, and CoQ10 status also provide context for metabolic capacity and cellular resilience.

Providers may recommend NAD+ if biomarkers show depleted levels, mitochondrial stress, or age-related metabolic decline. However, supplementation without baseline assessment risks ineffective spending and may mask underlying metabolic issues requiring different interventions.

Safety Considerations and Provider-Guided Selection

NAD+ precursors are generally well-tolerated, though niacin can cause flushing and hepatic stress at high doses. NMN and NR have limited long-term human safety data; most trials span weeks to months. Individuals with liver disease, kidney impairment, or certain medications should consult providers before starting.

NAD+ supplementation is not a standalone solution for aging or metabolic disease. It works best as one component of a comprehensive plan including fitness, nutrition, sleep, and stress management—all assessed and guided by qualified providers familiar with your full health picture.

How PlexusDx Supports a More Personalized Approach

While NAD+ targets mitochondrial energy and cellular repair, peptide therapies like GLP-1 and tirzepatide address metabolic regulation and body composition. Biomarker and genetic assessment helps providers determine whether NAD+ support, peptide optimization, or both align with your precision wellness strategy.

The Precision Peptide Genetic Test reveals predispositions in GLP1R, GIPR, FTO, and MC4R pathways, offering context for how your genetics may influence metabolic regulation. While NAD+ function isn't directly predicted by these variants, understanding your metabolic genetic profile may help guide whether NAD+ supplementation supports or complements peptide-based interventions.

Discussing NAD+ benefits with your provider should include genetic insights, current biomarker status, and metabolic goals. This information can support a more informed conversation about which cellular and metabolic pathways need support—and whether NAD+, peptide therapies, or a combined approach best fits your individual biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the clinical evidence for NAD+ supplementation in aging?

Mouse studies show NAD+ restoration improves mitochondrial function and muscle endurance. Human trials are limited and typically short-term, with mixed results in muscle strength and metabolic markers. Long-term safety and efficacy data remain emerging.

How do I know if my NAD+ levels are actually low?

Specialized biomarker testing can measure blood NAD+ and related metabolites like lactate and ATP. However, most standard medical labs do not offer NAD+ testing. A functional medicine provider can guide appropriate assessment and interpretation.

Can NAD+ supplementation work alongside peptide therapies like semaglutide?

NAD+ and peptide therapies target different metabolic pathways. Combined use may be appropriate in some cases, but requires provider oversight to avoid interactions and ensure complementary benefit rather than redundancy.

Are there side effects or drug interactions with NAD+ precursors?

NMN and NR are generally well-tolerated with minimal reported side effects. Niacin can cause flushing and liver stress at high doses. Always disclose NAD+ use to your provider, especially if taking medications that affect nicotinamide metabolism.

Does the Precision Peptide Genetic Test predict NAD+ response?

No. The test reveals predispositions in peptide-pathway genes (GLP1R, GIPR, FTO, MC4R). NAD+ metabolism depends on different genes and biochemistry. However, understanding your metabolic genetic profile can inform whether NAD+ fits your overall precision wellness strategy.

NAD+ Benefits: Biomarker Context and Provider-Guided Selection

NAD+ supports cellular energy production and DNA repair, with emerging evidence in aging and metabolic health. Biomarker assessment and provider guidance are essential for determining whether NAD+ supplementation aligns with individual health goals.